JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 38 No. 5 821-826
© 1997 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, A.
Right arrow Articles by Marzilli, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, A.
Right arrow Articles by Marzilli, L. G.

Comparison of Technetium-99m-LL-EC Isomers in Rats and Humans

Andrew Taylor, Lory Hansen, Dennis Eshima, Eugene Malveaux, Russell Folks, Lorie Shattuck, Malgorzata Lipowska and Luigi G. Marzilli

Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine and Department of Chemistry, Emory University, Atlanta, Georgia

Correspondence: For correspondence or reprints contact: Andrew Taylor, Jr., MD, Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine, 1364 Clifton Rd., Atlanta, GA 30322.

ABSTRACT

Technetium-99m-L,L-ethylenedicysteine (99mTc-L,L-EC)is a new renal imaging agent with pharmacokinetic properties reported to be slightly superior to those of 99mTc-mercaptoacetyltriglycine (99mTc MAG3); however, to better define the potential of the enantiomer 99mTc-DD-EC and the diastereomer 99mTc-DL-EC as renal imaging agents, we compared the three EC stereoisomers with 131I-orthoiodohippurate (OIH) in a series of rats and humans. Methods: Each 99mTc-EC stereoisomer was coinjected with OIH in six Sprague-Dawley rats for measurements of clearance and extraction fraction. Each stereoisomer was also coinjected wfth OIH in three human volunteers followed by sequential imaging, plasma clearance measurements and timed urine collections. Results: Technetium-99m-DD-EC had the highest clearance and extraction efficiency in rats (p ≥ 0.02). In humans, image quality was good with all three agents. The clearance ratio (EC/OIH) was 82% ± 8% for 99mTc-DD-EC compared to 70% ± 3% and 40% ± 5% for 99mTc-L,L-EC and 99mTc-DL-EC, respectivaly. Technetium-99m-DD and 99mTc-L,L-EC were excreted more rapidly than 99mTc-DL-EC. Conclusion: Technetium-99m-DD-EC has excellent imaging properties and the data suggest that its clearance may approach that of OIH more closely than any other 99mTc renal agent. A potential limitationis the fact that both 99mTc-DD and LL-EC exist in dianionic (80%) and monoanionic (20%) forms at physiological pH and it is unlikely that these two forms have the same clearance or protein binding affinity.

Key Words: technetium-99m-DD-EC • technetium-99m-L,L-EC • tectinetium-99m-DL-EC • renal scintigraphy




This article has been cited by other articles:


Home page
JNMHome page
M. Lipowska, H. He, E. Malveaux, X. Xu, L. G. Marzilli, and A. Taylor
First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans
J. Nucl. Med., June 1, 2006; 47(6): 1032 - 1040.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. T. Taylor, M. Lipowska, L. Hansen, E. Malveaux, and L. G. Marzilli
99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC
J. Nucl. Med., May 1, 2004; 45(5): 885 - 891.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Eshima, L. Eshima, L. Hansen, M. Lipowska, L. G. Marzilli, and A. Taylor Jr
Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents
J. Nucl. Med., December 1, 2000; 41(12): 2077 - 2082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1997 by the Society of Nuclear Medicine.